Strategic Advisory & Clinical Leadership
When Innovation Must Deliver in Practice
Keynotes create shared understanding. Advisory ensures technology delivers in clinical practice.
Barry P. Chaiken, MD partners with venture-backed and growth-stage companies, bringing complex solutions into real-world care.
Artificial intelligence is one domain. The broader challenge is aligning technology with workflow, governance discipline, market readiness, and institutional trust.
WHO IT SERVES
For Leaders Accountable for Outcomes
Venture-backed healthcare technology companies (Seed–Series B)
Founder-led startups preparing for scale
Growth-stage companies entering clinical markets
Health systems adopting emerging technologies
Investors evaluating product safety and market viability
HOW HE CONTRIBUTES
Advisory Grounded in Clinical and Market Reality
This is not slide-driven management consulting. It is executive partnership shaped by clinical workflow, public health discipline, and the realities of bringing healthcare technology to market.
Cross-Functional Clinical Leadership
Working across product, engineering, commercial strategy, and governance to ensure technology aligns with real-world care delivery.
Clear Accountability
Recommendations tied to adoption, risk reduction, market viability, and long-term institutional trust—not trend alignment.
STRATEGIC DOMAINS
Where Decisions Become Actions
Go-to-Market & Commercialization
Ensuring healthcare technology is positioned for real-world adoption. Translating product capability into clinical value, market readiness, and defensible differentiation.
Fractional Chief Medical Officer
Clinical leadership for Seed–Series B companies requiring embedded oversight without full-time executive overhead. Aligning product direction, governance, commercialization, and investor credibility early in growth.
Governance & Risk Oversight
Integrating safety, accountability, and systems thinking into technology development. Applying disciplined monitoring principles across AI and broader healthcare IT initiatives.
Executive & Investor Advisory
Supporting leadership teams and investors in evaluating clinical risk, market viability, and growth decisions that must withstand scrutiny. Clarifying exposure before capital is deployed and scale accelerates.
Clinical Advisory Board Design
Building advisory structures that provide substantive expertise, not symbolic endorsement. Identifying, recruiting, and guiding experts who meaningfully shape product direction and credibility.
ENGAGEMENT MODELS
Structured to Match the Moment
Every engagement begins with a disciplined conversation to define scope, risk, decision context, and measurable outcomes before commitments are made.
Strategic advisory retainers
Fractional Chief Medical Officer engagements
Executive and board-level support
Go-to-market advisory
Clinical advisory board design and guidance
Let’s Talk About What’s at Stake
Start with a strategic conversation.
If your organization is bringing healthcare technology into clinical practice—or preparing to scale responsibly—begin with a strategic conversation to clarify the decisions at stake and the most useful next step.